DocSym
β
Searchsearch
Search
(G73.3*) Myasthenic syndromes in other diseases classified elsewhere
More details coming soon
NaN% mortality rate associated with the disease myasthenic syndromes in other diseases classified elsewhere
Diagnosis myasthenic syndromes in other diseases classified elsewhere is diagnosed Prevalent in Women Only
0
Men receive the diagnosis myasthenic syndromes in other diseases classified elsewhere
0 (No mortality)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
0
Women receive the diagnosis myasthenic syndromes in other diseases classified elsewhere
0 (No mortality)Died from this diagnosis.
Risk Group for the Disease myasthenic syndromes in other diseases classified elsewhere - Men and Women aged 0
No Cases of the Disease Myasthenic syndromes in other diseases classified elsewhere identified in Men
Less common in men the disease occurs at Age 0-95+Less common in women the disease occurs at Age 0-95+
No Cases of the Disease Myasthenic syndromes in other diseases classified elsewhere identified in Men
Disease Features myasthenic syndromes in other diseases classified elsewhere
Absence or low individual and public risk
Myasthenic syndromes in other diseases classified elsewhere - what does this mean
Myasthenic syndromes in other diseases classified elsewhere are a group of neuromuscular disorders caused by an abnormality in the transmission of nerve impulses to the muscles. these disorders can be caused by a variety of factors, including diseases of the nervous system, autoimmune disorders, metabolic disorders, and genetic mutations. symptoms of myasthenic syndromes may include muscle weakness, fatigue, and difficulty with coordination and balance. treatment may include medications, physical and occupational therapy, and surgical procedures.
What happens during the disease - myasthenic syndromes in other diseases classified elsewhere
Myasthenic syndromes occur when there is an abnormality in the transmission of signals between the nerve and muscle, leading to a decrease in the strength of muscle contractions. this can be caused by a disruption in the production, release, or binding of the neurotransmitter acetylcholine, or by antibodies that block the receptors for acetylcholine, resulting in impaired neuromuscular transmission.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Muscle biopsy
- Electromyography
- Single-fiber electromyography
- Neurophysiological tests
- Imaging tests
- Genetic testing
Treatment and Medical Assistance
Main Goal: To reduce the symptoms of myasthenic syndromes in other diseases classified elsewhere.
- Administering medications to reduce muscle weakness, such as anticholinesterase agents, immunosuppressants, and corticosteroids.
- Physical therapy to maintain and improve muscle strength and function.
- Monitoring of vital signs to detect any changes in the condition.
- Nutritional support to ensure adequate nutrition.
- Surgery to remove tumors or other abnormalities.
- Plasmapheresis to remove antibodies from the blood.
- Intravenous immunoglobulin (IVIG) to reduce inflammation.
- Ventilation support to maintain adequate oxygen levels.
- Stem cell transplantation to replace damaged cells.
- Gene therapy to correct genetic defects.
No Hospitalization Required
Average Time for Outpatient Care Not Established
Myasthenic syndromes in other diseases classified elsewhere - Prevention
Prevention of myasthenic syndromes in other diseases classified elsewhere can be achieved through early detection and treatment of the underlying condition. this may include lifestyle modifications, such as exercise, diet, and stress reduction, as well as medications and/or other therapies. additionally, regular monitoring of symptoms and routine check-ups with a doctor can help to ensure that the condition is properly managed.